INAB IN8BIO, INC.
Healthcare · Market cap: $8.1M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $5.4M | $0 |
| 2022-Q4 | $186.0K | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $28.4K | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$5.7M18 buy days
Sold$00 sell days
Net insider flow+$5.7Mnet buying · 5 years
Latest trade2023-09-13Graff Jeremy R.
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2023-09-13 | Buy | Graff Jeremy R. | Director | 2,500 | $0.95 | $2.4K | 1 |
| 2023-08-25 | Buy | McCall Patrick | CFO | 1,000 | $1.03 | $1.0K | 1 |
| 2023-08-24 | Buy | Ho William Tai-Wei | CEO | 23,800 | $1.05 | $25.0K | 1 |
| 2022-12-12 | Buy | Kreis Leslie W. | Director | 75,001 | $2.48 | $186.0K | 3 |
| 2022-09-28 | Buy | Fletcher Aaron G.L. | Director | 25,000 | $2.02 | $50.5K | 3 |
| 2022-08-29 | Buy | Fletcher Aaron G.L. | Director | 40,000 | $2.02 | $80.8K | 3 |
| 2022-08-26 | Buy | Fletcher Aaron G.L. | Director | 11,214 | $2.01 | $22.5K | 3 |
| 2022-08-17 | Buy | Kreis Leslie W. | Director | 50,000 | $1.93 | $96.5K | 3 |
| 2022-08-16 | Buy | Kreis Leslie W. | Director | 1,773,684 | $1.90 | $3.4M | 3 |
| 2022-08-16 | Buy | FAIRBAIRN EMILY | Director | 789,473 | $1.90 | $1.5M | 1 |
| 2022-08-16 | Buy | Brandt Peter C. | Director | 105,263 | $1.90 | $200.0K | 1 |
| 2022-08-16 | Buy | Ho William Tai-Wei | CEO | 26,315 | $1.90 | $50.0K | 1 |
| 2022-08-16 | Buy | Roemer Alan S. | Director | 26,315 | $1.90 | $50.0K | 1 |
| 2022-08-16 | Buy | McCall Patrick | CFO | 5,263 | $1.90 | $10.0K | 1 |
| 2022-08-16 | Buy | Rochlin Kate | COO | 5,263 | $1.90 | $10.0K | 1 |
| 2022-08-16 | Buy | Goswami Trishna | Other C-suite | 2,631 | $1.90 | $5.0K | 1 |
| 2022-08-16 | Buy | Lamb Lawrence | Other C-suite | 526 | $1.90 | $999 | 1 |
| 2022-08-16 | Buy | Greenwood Luba | Director | 526 | $1.90 | $999 | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Kreis Leslie W. | Director | $3.8M | $0 | 2022-12-12 |
| FAIRBAIRN EMILY | Director | $1.5M | $0 | 2022-08-16 |
| Brandt Peter C. | Director | $200.0K | $0 | 2022-08-16 |
| Ho William Tai-Wei | CEO | $75.0K | $0 | 2023-08-24 |
| Roemer Alan S. | Director | $50.0K | $0 | 2022-08-16 |
| McCall Patrick | CFO | $11.0K | $0 | 2023-08-25 |
| Rochlin Kate | COO | $10.0K | $0 | 2022-08-16 |
| Goswami Trishna | Other C-suite | $5.0K | $0 | 2022-08-16 |
| Graff Jeremy R. | Director | $2.4K | $0 | 2023-09-13 |
| Greenwood Luba | Director | $999 | $0 | 2022-08-16 |
| Lamb Lawrence | Other C-suite | $999 | $0 | 2022-08-16 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2023-08-24 → 2023-09-13 | 3 | $28.4K | 39 | +6.6% (+2.3% raw) | +99.8% (+107.6% raw) | +19.5% (+30.4% raw) | closed |
| 2022-08-16 → 2022-09-28 | 10 | $5.4M | 74 | +31.6% (+22.1% raw) | -14.3% (-21.1% raw) | +2.3% (-1.6% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.